Anti transglutaminase antibodies cause ataxia in mice

Sabrina Boscolo, Andrea Lorenzon, Daniele Sblattero, Fiorella Florian, Marco Stebel, Roberto Marzari, Tarcisio Not, Daniel Aeschlimann, Alessandro Ventura, Marios Hadjivassiliou, Enrico Tongiorgi

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Background: Celiac disease (CD) is an autoimmune gastrointestinal disorder characterized by the presence of antitransglutaminase 2 (TG2) and anti-gliadin antibodies. Amongst the neurological dysfunctions associated with CD, ataxia represents the most common one. Methods: We analyzed by immunohistochemistry, the anti-neural reactivity of the serum from 20 CD patients. To determine the role of anti-TG2 antibodies in ataxia, two anti-TG2 single chain variable fragments (scFv), isolated from a phage-display IgA antibody library, were characterized by immunohistochemistry and ELISA, and injected in mice to study their effects on motor coordination. We found that 75% of the CD patient population without evidence of neurological involvement, has circulating anti-neural IgA and/or IgG antibodies. Two anti-TG2 scFvs, cloned from one CD patient, stained blood vessels but only one reacted with neurons. This anti-TG2 antibody showed cross reactivity with the transglutaminase isozymes TG3 and TG6. Intraventricular injection of the anti-TG2 or the anti-TG2/3/6 cross-reactive scFv provoked transient, equally intensive ataxia in mice. Conclusion: The serum from CD patients contains anti-TG2, TG3 and TG6 antibodies that may potentially cause ataxia.

Original languageEnglish
Article numbere9698
JournalPLoS One
Volume5
Issue number3
DOIs
Publication statusPublished - 2010

Fingerprint

Transglutaminases
celiac disease
protein-glutamine gamma-glutamyltransferase
Celiac Disease
Ataxia
Anti-Idiotypic Antibodies
antibodies
Antibodies
mice
Immunoglobulin A
immunohistochemistry
Immunohistochemistry
Intraventricular Injections
Gliadin
Single-Chain Antibodies
Bacteriophages
gliadin
Blood vessels
digestive system diseases
Serum

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Boscolo, S., Lorenzon, A., Sblattero, D., Florian, F., Stebel, M., Marzari, R., ... Tongiorgi, E. (2010). Anti transglutaminase antibodies cause ataxia in mice. PLoS One, 5(3), [e9698]. https://doi.org/10.1371/journal.pone.0009698

Anti transglutaminase antibodies cause ataxia in mice. / Boscolo, Sabrina; Lorenzon, Andrea; Sblattero, Daniele; Florian, Fiorella; Stebel, Marco; Marzari, Roberto; Not, Tarcisio; Aeschlimann, Daniel; Ventura, Alessandro; Hadjivassiliou, Marios; Tongiorgi, Enrico.

In: PLoS One, Vol. 5, No. 3, e9698, 2010.

Research output: Contribution to journalArticle

Boscolo, S, Lorenzon, A, Sblattero, D, Florian, F, Stebel, M, Marzari, R, Not, T, Aeschlimann, D, Ventura, A, Hadjivassiliou, M & Tongiorgi, E 2010, 'Anti transglutaminase antibodies cause ataxia in mice', PLoS One, vol. 5, no. 3, e9698. https://doi.org/10.1371/journal.pone.0009698
Boscolo S, Lorenzon A, Sblattero D, Florian F, Stebel M, Marzari R et al. Anti transglutaminase antibodies cause ataxia in mice. PLoS One. 2010;5(3). e9698. https://doi.org/10.1371/journal.pone.0009698
Boscolo, Sabrina ; Lorenzon, Andrea ; Sblattero, Daniele ; Florian, Fiorella ; Stebel, Marco ; Marzari, Roberto ; Not, Tarcisio ; Aeschlimann, Daniel ; Ventura, Alessandro ; Hadjivassiliou, Marios ; Tongiorgi, Enrico. / Anti transglutaminase antibodies cause ataxia in mice. In: PLoS One. 2010 ; Vol. 5, No. 3.
@article{fa1cf0e3ee2c4a7fa605791ad5138279,
title = "Anti transglutaminase antibodies cause ataxia in mice",
abstract = "Background: Celiac disease (CD) is an autoimmune gastrointestinal disorder characterized by the presence of antitransglutaminase 2 (TG2) and anti-gliadin antibodies. Amongst the neurological dysfunctions associated with CD, ataxia represents the most common one. Methods: We analyzed by immunohistochemistry, the anti-neural reactivity of the serum from 20 CD patients. To determine the role of anti-TG2 antibodies in ataxia, two anti-TG2 single chain variable fragments (scFv), isolated from a phage-display IgA antibody library, were characterized by immunohistochemistry and ELISA, and injected in mice to study their effects on motor coordination. We found that 75{\%} of the CD patient population without evidence of neurological involvement, has circulating anti-neural IgA and/or IgG antibodies. Two anti-TG2 scFvs, cloned from one CD patient, stained blood vessels but only one reacted with neurons. This anti-TG2 antibody showed cross reactivity with the transglutaminase isozymes TG3 and TG6. Intraventricular injection of the anti-TG2 or the anti-TG2/3/6 cross-reactive scFv provoked transient, equally intensive ataxia in mice. Conclusion: The serum from CD patients contains anti-TG2, TG3 and TG6 antibodies that may potentially cause ataxia.",
author = "Sabrina Boscolo and Andrea Lorenzon and Daniele Sblattero and Fiorella Florian and Marco Stebel and Roberto Marzari and Tarcisio Not and Daniel Aeschlimann and Alessandro Ventura and Marios Hadjivassiliou and Enrico Tongiorgi",
year = "2010",
doi = "10.1371/journal.pone.0009698",
language = "English",
volume = "5",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Anti transglutaminase antibodies cause ataxia in mice

AU - Boscolo, Sabrina

AU - Lorenzon, Andrea

AU - Sblattero, Daniele

AU - Florian, Fiorella

AU - Stebel, Marco

AU - Marzari, Roberto

AU - Not, Tarcisio

AU - Aeschlimann, Daniel

AU - Ventura, Alessandro

AU - Hadjivassiliou, Marios

AU - Tongiorgi, Enrico

PY - 2010

Y1 - 2010

N2 - Background: Celiac disease (CD) is an autoimmune gastrointestinal disorder characterized by the presence of antitransglutaminase 2 (TG2) and anti-gliadin antibodies. Amongst the neurological dysfunctions associated with CD, ataxia represents the most common one. Methods: We analyzed by immunohistochemistry, the anti-neural reactivity of the serum from 20 CD patients. To determine the role of anti-TG2 antibodies in ataxia, two anti-TG2 single chain variable fragments (scFv), isolated from a phage-display IgA antibody library, were characterized by immunohistochemistry and ELISA, and injected in mice to study their effects on motor coordination. We found that 75% of the CD patient population without evidence of neurological involvement, has circulating anti-neural IgA and/or IgG antibodies. Two anti-TG2 scFvs, cloned from one CD patient, stained blood vessels but only one reacted with neurons. This anti-TG2 antibody showed cross reactivity with the transglutaminase isozymes TG3 and TG6. Intraventricular injection of the anti-TG2 or the anti-TG2/3/6 cross-reactive scFv provoked transient, equally intensive ataxia in mice. Conclusion: The serum from CD patients contains anti-TG2, TG3 and TG6 antibodies that may potentially cause ataxia.

AB - Background: Celiac disease (CD) is an autoimmune gastrointestinal disorder characterized by the presence of antitransglutaminase 2 (TG2) and anti-gliadin antibodies. Amongst the neurological dysfunctions associated with CD, ataxia represents the most common one. Methods: We analyzed by immunohistochemistry, the anti-neural reactivity of the serum from 20 CD patients. To determine the role of anti-TG2 antibodies in ataxia, two anti-TG2 single chain variable fragments (scFv), isolated from a phage-display IgA antibody library, were characterized by immunohistochemistry and ELISA, and injected in mice to study their effects on motor coordination. We found that 75% of the CD patient population without evidence of neurological involvement, has circulating anti-neural IgA and/or IgG antibodies. Two anti-TG2 scFvs, cloned from one CD patient, stained blood vessels but only one reacted with neurons. This anti-TG2 antibody showed cross reactivity with the transglutaminase isozymes TG3 and TG6. Intraventricular injection of the anti-TG2 or the anti-TG2/3/6 cross-reactive scFv provoked transient, equally intensive ataxia in mice. Conclusion: The serum from CD patients contains anti-TG2, TG3 and TG6 antibodies that may potentially cause ataxia.

UR - http://www.scopus.com/inward/record.url?scp=77956185452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956185452&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0009698

DO - 10.1371/journal.pone.0009698

M3 - Article

VL - 5

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e9698

ER -